stella
beta
Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC) — Stella
Recruiting
Back to Biliary Tract Cancers trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
SKCCC Johns Hopkins Medical Institution, Baltimore, Maryland
View full record on ClinicalTrials.gov